Association of efavirenz hypersusceptibility with virologic response in ACTG 368, a randomized trial of abacavir (ABC) in combination with efavirenz (EFV) and indinavir (IDV) in HIV-infected subjects with prior nucleoside analog experience (Q33649563)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Association of efavirenz hypersusceptibility with virologic response in ACTG 368, a randomized trial of abacavir (ABC) in combination with efavirenz (EFV) and indinavir (IDV) in HIV-infected subjects with prior nucleoside analog experience |
scientific article |
Statements
1 reference
Association of efavirenz hypersusceptibility with virologic response in ACTG 368, a randomized trial of abacavir (ABC) in combination with efavirenz (EFV) and indinavir (IDV) in HIV-infected subjects with prior nucleoside analog experience (English)
1 reference
Scott Hammer
1 reference
Susan Eshleman
1 reference
Joseph J Eron
1 reference
Margaret Fischl
1 reference
Lisa M Demeter
1 reference
Victor DeGruttola
1 reference
Stephanie Lustgarten
1 reference
Daniel Bettendorf
1 reference
William Spreen
1 reference
Bach-Yen Nguyen
1 reference
Christine E Koval
1 reference
Kathleen Squires
1 reference
1 January 2008
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference